Diffuse large B-cell lymphoma trials in Peru
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2/3RecruitingTrial-stage medicine
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Chiclayo, Lima, Surquillo
- Age
- 18 years and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017EU 2022-502646-27-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Chiclayo, Lima, Surquillo
- Age
- 18 years and over
- People
- 1,046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347EU 2024-515566-13-00Registry updated 2026-10-21
All Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.